Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$724.87 - $909.04 $3.02 Million - $3.78 Million
-4,161 Reduced 66.33%
2,112 $1.91 Million
Q1 2024

May 14, 2024

BUY
$592.2 - $792.28 $1.19 Million - $1.6 Million
2,014 Added 47.29%
6,273 $4.88 Million
Q4 2023

Feb 09, 2024

BUY
$525.19 - $619.13 $1.34 Million - $1.58 Million
2,548 Added 148.92%
4,259 $2.48 Million
Q3 2023

Nov 14, 2023

BUY
$434.7 - $599.3 $743,771 - $1.03 Million
1,711 New
1,711 $919,000
Q2 2022

Aug 12, 2022

SELL
$278.73 - $327.27 $948,239 - $1.11 Million
-3,402 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$234.69 - $291.66 $349,218 - $433,990
1,488 Added 77.74%
3,402 $974,000
Q4 2021

Feb 14, 2022

BUY
$224.85 - $279.04 $215,631 - $267,599
959 Added 100.42%
1,914 $529,000
Q3 2021

Nov 15, 2021

BUY
$221.6 - $272.71 $211,628 - $260,438
955 New
955 $220,000
Q4 2020

Feb 11, 2021

SELL
$130.46 - $172.63 $1.04 Million - $1.37 Million
-7,957 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$146.22 - $169.13 $1.16 Million - $1.35 Million
7,957 New
7,957 $1.18 Million
Q4 2018

Feb 13, 2019

SELL
$105.9 - $118.64 $1.11 Million - $1.25 Million
-10,516 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$85.86 - $107.31 $495,669 - $619,500
5,773 Added 121.72%
10,516 $1.13 Million
Q2 2018

Aug 14, 2018

BUY
$75.7 - $86.88 $359,045 - $412,071
4,743 New
4,743 $405,000
Q1 2018

May 14, 2018

SELL
$74.21 - $87.6 $924,656 - $1.09 Million
-12,460 Closed
0 $0
Q4 2017

Feb 09, 2018

BUY
$81.94 - $87.89 $1.02 Million - $1.1 Million
12,460
12,460 $1.05 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $713B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Dynamic Technology Lab Private LTD Portfolio

Follow Dynamic Technology Lab Private LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

News

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.